5% STAKE4582.TTSE GROWTHUNITED STATES

Heights Capital Management lowers stake in SymBio Pharmaceuticals to 4.18%

Stake history

2%4%6%8%10%7.22%PriorPrior: 7.22% · prior ratio stated in S100U2YX4.18%Jul 25Jul 25: 4.18% · S100U2YX
2%4%6%8%10%7.22%PriorPrior: 7.22% · prior ratio stated in S100U2YX4.18%Jul 25Jul 25: 4.18% · S100U2YX

Summary

Heights Capital Management, Inc. filed a Change in 5%+ stake (change report) via EDINET on 2024-07-25 15:23 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 4.18%, previous report: 7.22%.

Open the price chart on TradingView.

Source: EDINET S100U2YX ↗ · PDL1.0 · Not investment advice